BIOMAT Database Logo BIOMAT Database Logo

Cysteinyl leukotrienes modulate angiotensin II constrictor effects on aortas from streptozotocin-induced diabetic rats. 2001

G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Laboratory of Pharmacology, University of Medicine, LSCPA EA2937, La Tronche, France.

Angiotensin II (Ang II) is a vasopressor peptide involved in the pathogenesis of cardiovascular diseases associated with diabetes mellitus. We have previously reported that the 5-lipoxygenase-derived products, particularly the cysteinyl leukotrienes (CysLTs), are involved in Ang II-induced contraction. In this study, we demonstrated that CysLTs contribute to the contraction elicited by Ang II in isolated aortas from streptozotocin-induced diabetic (SS) rats but not from insulin-treated diabetic rats, fructose-fed rats, or control rats. In an organ bath, pretreatment with the 5-lipoxygenase inhibitor (AA861, 10 micromol/L) reduced by 37.6+/-8.2% and 30.1+/-10.9% the Ang II-induced contractions in intact and endothelium-denuded aortic rings, respectively, from SS rats. In contrast, the CysLT(1) receptor antagonist (MK571, 1 micromol/L) or the dual CysLT(1)/CysLT(2) receptor antagonist (BAY-u9773, 0.1 micromol/L) did not affect Ang II-induced contraction. In addition, Ang II induced a 6.2+/-1.5-fold increase in CysLT release through the stimulation of the Ang II type 1 receptor. Furthermore, the urinary excretion of leukotriene E(4) was increased in SS rats (leukotriene E(4), 13.7+/-2.9 ng/24 h [SS rats, n=10] versus 1.5+/-0.5 ng/24 h [control rats, n=6]; P<0.0004). These data suggest the activation of the 5-lipoxygenase pathway in SS rats and the involvement of 5-lipoxygenase-derived products, particularly the CysLTs, in Ang II-induced contraction in aortas from SS rats through stimulation of CysLT receptors different from the well-characterized CysLT(1) or CysLT(2) receptor.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009924 Organ Culture Techniques A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1) Organ Culture,Culture Technique, Organ,Culture Techniques, Organ,Organ Culture Technique,Organ Cultures
D011189 Potassium Chloride A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. Slow-K,Chloride, Potassium
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D011804 Quinolines
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas

Related Publications

G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Cysteinyl leukotrienes are involved in angiotensin II-induced contraction of aorta from spontaneously hypertensive rats.
January 2001, Cardiovascular research,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Effect of angiotensin II on glomerular structure in streptozotocin-induced diabetic rats.
January 2004, American journal of nephrology,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Decreased lactate transport in aortas from streptozotocin-diabetic rats.
January 1982, Blood vessels,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Hydrogen peroxide modulates angiotensin II-induced contraction of mesenteric arteries from streptozotocin-induced diabetic rats.
March 2007, Vascular pharmacology,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats.
July 2006, Diabetes research and clinical practice,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Losartan counteracts the hyper-reactivity to angiotensin II and ROCK1 over-activation in aortas isolated from streptozotocin-injected diabetic rats.
June 2009, Cardiovascular diabetology,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Renal angiotensin II AT2 receptors promote natriuresis in streptozotocin-induced diabetic rats.
February 2006, American journal of physiology. Renal physiology,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Effects of angiotensin II, adrenocorticotropin, and potassium on aldosterone production in adrenal zona glomerulosa cells from streptozotocin-induced diabetic rats.
January 1986, Endocrinology,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats.
February 2006, Diabetes,
G Hardy, and F Stanke-Labesque, and M Peoc'h, and A Hakim, and P Devillier, and F Caron, and S Morel, and P Faure, and S Halimi, and G Bessard
Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
April 2003, Journal of hypertension,
Copied contents to your clipboard!